Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pars plana vitrectomy in patients with intermediate uveitis.

P Stavrou1, S Baltatzis, E Letko

  • 1Immunology Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA 02114, USA.

Ocular Immunology and Inflammation
|January 30, 2002
PubMed
Summary

Pars plana vitrectomy improved intermediate uveitis in 44% of patients, reducing immunosuppression needs. This surgical approach also enhanced visual acuity in most eyes, offering a beneficial treatment option.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer.

British journal of cancer·2014
Same author

Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancer.

Prostate cancer and prostatic diseases·2012
Same author

Atopic keratoconjunctivitis.

Ocular immunology and inflammation·2012
Same author

Splice variant PRKC-ζ(-PrC) is a novel biomarker of human prostate cancer.

British journal of cancer·2012
Same author

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort.

British journal of cancer·2012
Same author

Difluprednate for inflammatory eye disorders.

Drugs of today (Barcelona, Spain : 1998)·2011

Area of Science:

  • Ophthalmology
  • Surgical Interventions
  • Inflammatory Eye Diseases

Background:

  • Intermediate uveitis is an ocular inflammatory condition requiring management.
  • Complications include cystoid macular edema and vision loss.
  • Immunosuppressive therapy is often necessary but carries risks.

Purpose of the Study:

  • To evaluate the efficacy of pars plana vitrectomy in managing intermediate uveitis.
  • To assess the impact on uveitis course, cystoid macular edema, and visual acuity.
  • To determine if pars plana vitrectomy can reduce the need for immunosuppression.

Main Methods:

  • Retrospective analysis of 32 patients (43 eyes) with intermediate uveitis.
  • Pars plana vitrectomy, with or without cataract surgery, was performed.

Related Experiment Videos

  • Clinical course, visual outcomes, and complications were monitored.

    • Main Results:

    • 44.1% of eyes showed improved uveitis, enabling immunosuppression discontinuation in 7 patients.
    • Cystoid macular edema resolved in 32.4% of affected eyes.
    • Visual acuity improved or was maintained in 93% of eyes; 7% experienced deterioration.

    Conclusions:

    • Pars plana vitrectomy demonstrates a beneficial effect on intermediate uveitis course and complications.
    • The procedure may reduce the reliance on long-term immunosuppressive treatments.
    • Combining pars plana vitrectomy with cataract surgery can enhance visual outcomes.